Divi's Laboratories Limited
DIVISLAB.NS
₹9575.00
▲ 2.79%
Divi's Laboratories led the pharma pack higher, climbing 2.79% to ₹9575, even as no specific trigger emerged for the day's move. The stock's longer-term chart tells a stronger story though, with a blistering 58.86% one-year CAGR and a 36.10% two-year CAGR that far outpaces most large-cap peers, though the pace has moderated to a still-healthy 13.49% over five years and 21.80% over a decade. A set of 29 analysts track the counter with an average target of ₹8447, which sits below the current market price, and the consensus reads as a hold — suggesting the recent rally may have run ahead of fundamentals in the eyes of the Street.
CAGR Performance
| 1 Year | 2 Years | 5 Years | 10 Years |
|---|---|---|---|
| 56.16% | 31.74% | 13.24% | 21.86% |
Analyst Consensus
Average Target Price: ₹8447.00 (range ₹6000.00 - ₹11700.00) based on 29 analysts
Strong Buy: 4
Buy: 10
Hold: 6
Sell: 3
Strong Sell: 6
Related News
No comments:
Post a Comment